Viewing Study NCT00326313



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00326313
Status: UNKNOWN
Last Update Posted: 2006-05-16
First Post: 2006-05-14

Brief Title: Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study
Sponsor: Sheba Medical Center
Organization: Sheba Medical Center

Study Overview

Official Title: Clinical Outcome of Neonate With GBS Positive Culture-12 Year Retrospective Study
Status: UNKNOWN
Status Verified Date: 2006-05
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Streptococci group B GBS is a the major reason for morbidity and mortality in neonates It can present as pneumonia meningitis or sepsisThe mortality today is 5-20 and even more in preterm babies

During the past two decade the introduction of protocols for prophylactic antibiotics for women with a high risk for GBS infection have led to a decline of 65 in GBS cases032 for 1000 live birth compared to 18 cases in 1000The purpose of the study is to check the morbidity and mortality at Sheba medical center in the last 12 years in children with positive blood culture for GBS We assume that in our hospital the morbidity and mortality is less then expected If proven right we would then check the reasons for that outcome considering the type and length of treatment and the different virulence of the streptococcus
Detailed Description: This is a retrospective case control study We will review from archive the charts of all the neonates with positive blood culture for GBS reviewing the course and severity of their illness

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None